Table 1.

Clinical Characteristics of Pulmonary Nocardiosis.

	No. (%) of Cases
Gender (male)	19	(63.3)
Mean Age, Yr. [range]	65.6 [25-88]
Non-pulmonary underlying disease	25	(83.3)
Hematologic malignancy	10	(33.3)
Solid tumor	5	(16.7)
Connective tissue disease, vasculitis	3	(10.0)
Cushing syndrome	2	(6.7)
Diabetes mellitus	2	(6.7)
Human immunodeficiency virus infection	2	(6.7)
Auto-immune hepatitis	1	(3.3)
Pulmonary underlying disease	9	(30.0)
Chronic obstructive pulmonary disease	3	(10.0)
Interstitial pneumonia	2	(6.7)
Bronchiectasis	2	(6.7)
Bronchial asthma	1	(3.3)
Non-tuberculous mycobacteria	1	(3.3)
No underlying disease	1	(3.3)
Immunosuppressant agents	13	(43.3)
Corticosteroids	8	(26.7)
Corticosteroids+Cyclosporin	4	(13.3)
Corticosteroids+Tacrolimus	1	(3.3)
Prophylaxis with sulfamethoxazole-trimethoprim	3	(10.0)